Clinical Trials Directory

Trials / Completed

CompletedNCT02592486

The Immunogenicity of Simultaneous Administration of Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Vaccine

A Randomized, Open-label, Parallel Design Study to Compare the Immunogenicity of Simultaneous Administration Versus Sequential Administration of Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Vaccine

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
162 (actual)
Sponsor
Kameda Medical Center · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

The immunogenicity of simultaneous administration of quadrivalent influenza vaccine and pneumococcal vaccine was unknown. The purpose of present study is to compare the immunogenicity of simultaneous administration of influenza vaccine and pneumococcal vaccine with that of separate administration.

Detailed description

The immunogenicity of simultaneous administration of quadrivalent influenza vaccine and pneumococcal vaccine was unknown. We compare the immunogenicity of simultaneous administration of quadrivalent influenza vaccine and pneumococcal vaccine with that of separate administration. 162 Participants are randomly assigned to one of the two study groups; Simultaneous administration group: receive injections of pneumococcal vaccine and influenza vaccine simultaneously. Sequential administration group: receive injections of pneumococcal vaccine 2 weeks after the injection of the influenza vaccine. We compare the immunogenicity of the two groups.

Conditions

Interventions

TypeNameDescription
BIOLOGICALSimultaneous administration of Pneumovax NP® and Fluvic HA syringe®Injections of pneumococcal vaccine and influenza vaccine simultaneously.
BIOLOGICALSequential administration of Pneumovax NP® and Fluvic HA syringe®Injections of pneumococcal vaccine 2 weeks after the injection of the influenza vaccine.

Timeline

Start date
2015-11-01
Primary completion
2016-03-01
Completion
2016-08-01
First posted
2015-10-30
Last updated
2019-01-31
Results posted
2019-01-31

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT02592486. Inclusion in this directory is not an endorsement.